Cargando…
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer
SIMPLE SUMMARY: Prostate cancer is the second most deadly cancer in American men. The mainstay of treatment, androgen deprivation therapy, is aimed at modifying the hormonal signals involved in growth of prostate tumors. Recent research has revealed an association between these therapies and increas...
Autores principales: | Fradin, James, Kim, Felix J., Lu-Yao, Grace L., Storozynsky, Eugene, Kelly, William K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136828/ https://www.ncbi.nlm.nih.gov/pubmed/37190244 http://dx.doi.org/10.3390/cancers15082316 |
Ejemplares similares
-
Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2021) -
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021) -
NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
por: Huang, Shu-Pin, et al.
Publicado: (2021) -
Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018) -
Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)